Appears on
Articles4
C5041006 sub study 1
C5041006 sub study 1 amsdenmb Mon, 06/08/2026 - 15:37 Velsipity etrasimod PHASE II Mon, 01/06/2020 - 12:00 Mon, 06/09/2025 - 12:00 NCT04173273 C5041006 SS1 Public Disclosure Synopsis _0.pdf (161.02 KB) N C5041006 sub study 1
C5041006 sub study A
C5041006 sub study A amsdenmb Mon, 06/08/2026 - 16:06 Velsipity etrasimod PHASE II Mon, 01/06/2020 - 12:00 Mon, 06/09/2025 - 12:00 NCT04173273 C5041006 Public Disclosure Synopsis_SSA_eng.pdf (138.69 KB) N C5041006 sub study A
C5041006 sub study 3
C5041006 sub study 3 amsdenmb Mon, 06/08/2026 - 16:21 Velsipity etrasimod PHASE II/III Mon, 01/06/2020 - 12:00 Mon, 06/09/2025 - 12:00 NCT04173273 C5041006 SS3 Public Disclosure Synopsis.pdf (160.8 KB) N C5041006 sub study 3
C5041006 sub study 4
C5041006 sub study 4 amsdenmb Mon, 06/08/2026 - 16:39 Velsipity etrasimod PHASE II/III Mon, 01/06/2020 - 12:00 Mon, 06/09/2025 - 12:00 NCT04173273 C5041006 SS4 Public Disclosure Synopsis.pdf (105.28 KB) N C5041006 sub study 4